Swiss National Bank
HLVX

Swiss National Bank’s HilleVax HLVX Stock Holding History

Swiss National Bank’s Portfolio HLVX Stock Details HLVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-38,200
Closed -$552K – 2475
2024
Q2 		$552K Hold
38,200
– – ﹤0.01% 2400
2024
Q1 		$635K Hold
38,200
– – ﹤0.01% 2406
2023
Q4 		$613K Buy
38,200
+7,000
+22% +$93K ﹤0.01% 2436
2023
Q3 		$420K Buy
31,200
+10,000
+47% +$141K ﹤0.01% 2540
2023
Q2 		$364K Hold
21,200
– – ﹤0.01% 2583
2023
Q1 		$350K Sell
21,200
-7,000
-25% -$112K ﹤0.01% 2588
2022
Q4 		$472K Buy
+28,200
New +$509K ﹤0.01% 2583

Other funds holding HLVX

FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
TPC
Takeda Pharmaceutical Company Tokyo, Japan $16.4M AUM 195.92% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
CG
Carlyle Group Washington, District of Columbia $10B AUM 10.61% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

Swiss National Bank's HLVX Position: Q3 2024 in Review

Swiss National Bank sold out of HilleVax (HLVX) in Q3 2024, closing a stake of 38,200 shares — an estimated $552K sold.

Swiss National Bank first reported a position in HLVX in Q4 2022 and held it in 7 quarters. The position peaked at $635K in Q1 2024. 79 funds tracked by Wall St. Rank hold HLVX as of Q3 2024.

  • Swiss National Bank reported no remaining HilleVax position as of Q3 2024 after selling out during the quarter.
  • Swiss National Bank sold 38,200 HilleVax shares in Q3 2024, an estimated $552K.
  • Swiss National Bank first reported a position in HilleVax in Q4 2022 and held it in 7 quarters.
  • Swiss National Bank's HilleVax position peaked at $635K in Q1 2024.
  • 79 funds tracked by Wall St. Rank held HilleVax as of Q3 2024.

Based on Swiss National Bank's 13F filing for Q3 2024, filed 7 Nov 2024.